Ranbaxy gets USFDA nod for to sell muscle relaxing tabs in US

Home-grown pharma major, Ranbaxy has received the US Food and Drug Administration's (USFDA) approval for selling cyclobenzaprine hydrochloride tablets used as muscle relaxant in different strengths in the US markets.

NEW DELHI: Home-grown pharma major, Ranbaxy has received the US Food and Drug Administration's (USFDA) approval for selling cyclobenzaprine hydrochloride tablets used as muscle relaxant in different strengths in the US markets.

The company has got the approval of USFDA to launch cyclobenzaprine hydrochloride in 5mg, 7.5 mg and 10 mg strengths, according to the information available on the website of USFDA.

Ranbaxy is a leading domestic drug manufacturer and the company has the largest number of USFDA approved drugs.
READ MORE
ADVERTISEMENT

LOGIN & CLAIM

50 TIMESPOINTS

More from our Partners

Loading next story
Business News › Industry › Healthcare/Biotech › Pharmaceuticals › Ranbaxy gets USFDA nod for to sell muscle relaxing tabs in US
Text Size:AAA
Success
This article has been saved

*

+